By Matt Jones

NEW YORK (GenomeWeb News) – The US Senate has spent much of this week considering a bill to reauthorize the soon-to-expire Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, just as the House of Representatives begins hearings on the program in preparation for its own bill.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.